Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma
Joanna Poźniak(VIB-KU Leuven Center for Cancer Biology), Julia Newton‐Bishop(National Cancer Institute), Anastasia Filia(Academy of Athens), Sathya Muralidhar(University of Leeds), Jérémie Nsengimana(University of Leeds), Mitchell P. Levesque(University of Zurich), Tracey Mell(University of Leeds), Mark Harland(Cancer Research UK), John R. Davies(St James's University Hospital), Juliette A. Randerson‐Moor(University of Leeds), Sandra N. Freiberger(University of Zurich), Joey Mark S. Diaz(University of Leeds), Alastair Droop(Wellcome Sanger Institute), Sabrina A. Hogan(University Hospital of Zurich), D. Timothy Bishop(University of Leeds), Sally J. O’Shea(University of Leeds), Jonathan P. Laye(University of Leeds), Graham P. Cook(St James's University Hospital)
Cited by 53
Related Papers
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
|Nature|2013|735
Gene for von Recklinghausen Neurofibromatosis Is in the Pericentromeric Region of Chromosome 17
|Science|1987|698
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
|Nature Communications|2020|694
Discovery of common and rare genetic risk variants for colorectal cancer
|Nature Genetics|2018|605